Unknown

Dataset Information

0

Humoral immunogenicity and reactogenicity of CoronaVac or ZF2001 booster after two doses of inactivated vaccine.

ABSTRACT:

SUBMITTER: Cao Y 

PROVIDER: S-EPMC8640508 | biostudies-literature | 2022 Jan

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Humoral immunogenicity and reactogenicity of CoronaVac or ZF2001 booster after two doses of inactivated vaccine.

Cao Yunlong Y   Hao Xiaohua X   Wang Xi X   Wu Qianhui Q   Song Rui R   Zhao Dong D   Song Weiliang W   Wang Yao Y   Yisimayi Ayijiang A   Wang Wei W   Zhang Wen W   Du Juan J   Yu Hongjie H   Xie Xiaoliang Sunney XS   Jin Ronghua R  

Cell research 20211203 1

Similar Datasets

Unknown Immunogenicity, reactogenicity and breakthrough infections after two doses of the inactivated CoronaVac vaccine among patients on dialysis: phase 4 study.
| S-EPMC8967539 | biostudies-literature
Unknown Safety and immunogenicity of heterologous recombinant protein subunit vaccine (ZF2001) booster against COVID-19 at 3-9-month intervals following two-dose inactivated vaccine (CoronaVac).
| S-EPMC9679005 | biostudies-literature
Unknown Assessing humoral immune response after two doses of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthcare workers.
| S-EPMC8786607 | biostudies-literature
Unknown Comparison of the reactogenicity and immunogenicity of a reduced and standard booster dose of the mRNA COVID-19 vaccine in healthy adults after two doses of inactivated vaccine.
| S-EPMC9393164 | biostudies-literature
Unknown Safety and immunogenicity of inactivated COVID-19 vaccine CoronaVac and the RBD-dimer-based COVID-19 vaccine ZF2001 in chronic hepatitis B patients.
| S-EPMC9944390 | biostudies-literature
Unknown Safety and immunogenicity of aerosolised Ad5-nCoV, intramuscular Ad5-nCoV, or inactivated COVID-19 vaccine CoronaVac given as the second booster following three doses of CoronaVac: a multicentre, open-label, phase 4, randomised trial.
| S-EPMC9991083 | biostudies-literature
Unknown Serological study of CoronaVac vaccine and booster doses in Chile: immunogenicity and persistence of anti-SARS-CoV-2 spike antibodies.
| S-EPMC9177225 | biostudies-literature
Unknown Immunogenicity and reactogenicity after booster dose with AZD1222 via intradermal route among adult who had received CoronaVac.
| S-EPMC9058819 | biostudies-literature
Unknown Immunogenicity and Safety of the Third Booster Dose with mRNA-1273 COVID-19 Vaccine after Receiving Two Doses of Inactivated or Viral Vector COVID-19 Vaccine.
| S-EPMC10053262 | biostudies-literature
Unknown Comparison of the Immunogenicity of Various Booster Doses of Inactivated Polio Vaccine Delivered Intradermally Versus Intramuscularly to HIV-Infected Adults.
| S-EPMC4539908 | biostudies-literature